Publication of Cancellation of Entries for Kinds of Medical Devices from the Australian Register of Therapeutic Goods - Danas Dental Supplies Pty Ltd - 204303

Overview

The Therapeutic Goods Act 1989 was enacted to regulate the provision of therapeutic goods in Australia, ensuring they are safe, of high quality, and effective for their intended use. The Act addresses the problem of inadequate regulation of therapeutic goods by providing a comprehensive framework for their control. The Act was passed by the Commonwealth Parliament with the policy objective of protecting public health and safety by regulating the supply, advertising, and representation of therapeutic goods. The Therapeutic Goods Administration, as the delegate of the Secretary to the Department of Health and Ageing, administers the Act and has the power to cancel entries for kinds of medical devices from the Australian Register of Therapeutic Goods if certain conditions are met. In line with this objective, the Therapeutic Goods Administration has the power to cancel entries for kinds of medical devices from the Australian Register of Therapeutic Goods if the device is incorrectly classified, the labelling does not comply with the essential principles, the sponsor is not identified in the product information, or if there is a failure to provide evidence that the conformity assessment procedures have been applied to the device. The cancellation of an entry from the Australian Register of Therapeutic Goods effectively prohibits the supply of the medical device in Australia, protecting the public from potentially unsafe or ineffective products.

Scope and Application

The Therapeutic Goods Act 1989 applies to a broad range of therapeutic goods, including medicines, medical devices, and blood and blood components, and governs their regulation throughout the Commonwealth of Australia. This Act provides the legal framework for the regulation of therapeutic goods and covers a variety of entities, including sponsors, manufacturers, importers, and suppliers of these goods. The scope of the Act extends to all therapeutic goods that are manufactured, supplied, advertised, or evaluated within Australia, and also applies to goods imported into Australia. The Act provides mechanisms for the control and oversight of therapeutic goods to ensure they meet the necessary safety, quality, and efficacy standards. Certain exclusions and exemptions may apply, particularly for goods intended for personal use, research, or clinical trials, as specified under the Act or in subordinate instruments. The Act allows for the establishment of specific regulations and standards through subordinate legislation, which can further detail the application and enforcement of the primary Act.

Key Provisions

Section 41GP of the Therapeutic Goods Act 1989 allows for the cancellation of entries for kinds of medical devices from the Australian Register of Therapeutic Goods under certain conditions. In this instance, the cancellation pertains to a suction tip, general-purpose, single use, with the ARTG number 204303. The cancellation was initiated by Rodolfo Ferrari, a delegate of the Secretary to the Department of Health and Ageing. The reasons for the cancellation include incorrect classification of the device, non-compliance with labelling requirements, failure to identify the sponsor in the product information, and lack of evidence that conformity assessment procedures were applied. The cancellation became effective on 13 September 2013. Under the Therapeutic Goods Act 1989, various obligations and requirements are imposed on the parties involved in the registration and distribution of therapeutic goods. For the sponsor, Danas Dental Supplies Pty Ltd, the obligations include ensuring that the device is correctly classified and that all required certifications are accurate. This includes verifying that the product information correctly identifies the sponsor, and that all labelling complies with the essential principles. Additionally, the sponsor must ensure that evidence of conformity assessment procedures is provided to substantiate the device's compliance with regulatory standards. Failure to meet these obligations can result in significant consequences. Section 41GN(1)(b) and (f) of the Act authorise the cancellation of entries from the Australian Register of Therapeutic Goods, which can render the device illegal for distribution or use in Australia. The Act does not explicitly state penalties for these offences but breaches of the Therapeutic Goods Act can result in civil or criminal penalties under other sections. These may include fines or imprisonment, depending on the severity of the breach and the intent behind it. The specific penalties would be determined by the courts, taking into account the circumstances of the case. It is crucial for sponsors, manufacturers, and other entities governed by the Therapeutic Goods Act to adhere to all requirements and obligations to avoid potential legal repercussions. Non-compliance not only risks the cancellation of product listings but may also lead to broader enforcement actions by the Therapeutic Goods Administration. These can include recalls, fines, and criminal charges, all of which can have serious implications for the entities involved.